LEUKEMIC PLASMACYTOID DENDRITIC CELL LINE TRANSDUCED WITH CATLR4 GENE AS A POTENT ANTIGEN PRESENTING CELLS FOR IMMUNOTHERAPYCYTOTHERAPYIF3.22015-06-010PREAI
Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 geneMOLECULAR MEDICINE REPORTSIF3.52015-04-246OAAI
Overcoming HLA restriction in clinical trials Immune monitoring of mRNA-loaded DC therapyONCOIMMUNOLOGYIF6.32014-11-0432OAAI
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patientsANNALS OF ONCOLOGYIF65.42013-10-01181PREAI
Modulation of Regulatory T Cell Function by Monocyte-Derived Dendritic Cells Matured through Electroporation with mRNA Encoding CD40 Ligand, Constitutively Active TLR4, and CD70JOURNAL OF IMMUNOLOGYIF3.42013-08-1548OAAI
Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In VivoMOLECULAR THERAPY-NUCLEIC ACIDSIF02013-01-0140OAAI
Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma PatientsMOLECULAR THERAPYIF122012-05-0188OA
Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor TherapyCANCER RESEARCHIF16.62012-04-01187OAAI
Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced MelanomaJOURNAL OF IMMUNOTHERAPYIF2.92011-06-01126PREAI
Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma PatientsCLINICAL CANCER RESEARCHIF10.22009-05-18177PREAI
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNAMOLECULAR THERAPYIF122008-06-01171OAAI
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cellsJOURNAL OF LEUKOCYTE BIOLOGYIF3.12007-04-2061OAAI
Dendritic cells differentiated in the presence of IFN-β and IL-3 are potent inducers of an antigen-specific CD8+ T cell responseJOURNAL OF LEUKOCYTE BIOLOGYIF3.12005-07-2129OAAI
Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapyJOURNAL OF GENE MEDICINEIF2.22005-02-0350PREAI
Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: Implications for cancer immunotherapy protocolsMOLECULAR THERAPYIF122004-10-0176OAAI
Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II moleculesJOURNAL OF IMMUNOLOGYIF3.42004-06-01206OAAI
Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cellsCANCER GENE THERAPYIF52003-08-2843PREAI
Lentivirally transduced dendritic cells as a tool for cancer immunotherapyJOURNAL OF GENE MEDICINEIF2.22003-04-23174OA